CAD & Atherosclerosis
Conference Coverage
Increased risk of heart attack confirmed in Sjögren’s syndrome patients
Key clinical point: The findings support monitoring for coronary artery disease in patients with Sjögren’s syndrome in addition to management and...
Guidelines
Upcoming ESC revascularization guidelines cement heart team’s role
Conference Coverage
Paclitaxel-eluting balloon shows high claudication efficacy
Key clinical point: A drug-eluting balloon produced stentlike patency after 1 year in superficial femoral and popliteal arteries.Major finding:...
Conference Coverage
LDL cholesterol not a good marker of CVD in type 1 diabetes
Key clinical point: In type 1 diabetes, the ratio of total cholesterol to HDL better predicted CVD than did LDL cholesterol level.Major finding:...
Conference Coverage
Weight loss greater with higher-dose liraglutide in diabetes
Key clinical point: An investigational 3-mg/day dose of liraglutide may be more effective than 1.8 mg for weight loss in diabetes.Major finding:...
Conference Coverage
Diabetes found in 17% of MI patients in registry
Key clinical point: Nearly one-fifth of MI patients have undiagnosed diabetes, and their 3-year mortality was similar whether they had a STEMI or...
Guidelines
VIDEO: ACC/AHA lipid guidelines and diabetes
Conference Coverage
CKD considered a type 2 diabetes risk equivalent in CAD patients
Key clinical point: Type 2 diabetes and chronic kidney disease contribute synergistically to cardiac event risk in patients with established...
Conference Coverage
International RA risk tool for CVD comes closer to reality
Key clinical point: An RA-specific calculator for 10-year CVD risk may soon be available.Major finding: The risk factors in models that used...
Guidelines
Poor cardiovascular health predicted cognitive impairment
Key clinical point: Intermediate or high cardiovascular health can lower the risk of cognitive impairment, compared with low CVH.
News
Adding insulin to metformin may raise CVD risks
Key clinical point: Adding a sulfonylurea to metformin appears safer than adding insulin in terms of cardiovascular outcomes.Major finding: The...